Role of Hematopoietic Growth Factors in AngiogenesisRibatti D.a · Vacca A.b · De Falco G.b · Ria R.b · Roncali L.a · Dammacco F.b
aDepartment of Human Anatomy and Histology, and bDepartment of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari, Italy
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
In early ontogeny, hematopoiesis is closely associated with angiogenesis. This article reviews recent studies of the effect of hematopoietic growth factors on several endothelial cell functions together with recent findings about angiogenesis and antiangiogenic therapies in hematopoietic malignancies such as leukemia, lymphoma and myeloma.
© 2001 S. Karger AG, Basel
Murray PDF: The development in vitro of blood of the chick embryo. Proc R Soc B 1934;111:497–524.
- Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiehand SJ, Holash HW, Holash HJ: Vascular-specific growth factor and blood vessel formation. Nature 2000;407:242–248.
- Ribatti D, Vacca A, Roncali L, Dammacco F: Hematopoiesis and angiogenesis: A link between two apparently independent processes. J Hematother Stem Cell Res 2000;9:13–19.
- Suda T, Takakura N, Oike Y: Hematopoiesis and angiogenesis. Int J Hematol 2000;71:99–107.
- Delassus S, Titley I, Enver T: Functional and molecular analysis of hematopoietic progenitors derived from the aorta-gonad-mesonephros region of the mouse embryo. Blood 1999;94:1495–1503.
- Jaffredo T, Gautier R, Brajeul V, Dieterlen-Lievre F: Tracing the progeny of the aortic hemangioblast in the avian embryo. Dev Biol 2000;224:204–214.
- Pardanaud L, Dieterlen-Lievre F: Manipulation of the angiopoietic/hematopoietic commitment in the avian embryo. Development 1999;126:617–627.
- Goodell MA: CD34+ or CD34–: Does it really matter? Blood 1999;94:2545–2547.
- Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N, Kuge K, Schafer B, Hossfeld DK, Fiedler W: In vitro differentiation of endothelial cells from Ac133-positive progenitor cells. Blood 2000;95:3106–3112.
- Takakura N, Waranabe T, Svenobu S, Yamada Y, Noda T, Ito Y, Satake M, Suda A: Role for hematopoietic stem cells in promoting angiogenesis. Cell 2000;102:199–209.
Mohle R, Green D, Moore MAS, Nachman RL, Rafii S: Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelet. Proc Natl Acad Sci USA 1997;94:633–637.
- Bussolino F, Bocchietto E, Silvagno F, Soldi R, Arese M, Mantovani A: Actions of molecules which regulate hemopoiesis on endothelial cells: Memoirs of common ancestors? Pathol Res Pract 1994;190:834–839.
- Bikfalvi A, Hanz ZC: Angiogenic factors are hematopoietic factors and vice versa. Leukemia 1994;8:523–529.
- Carlini RG, Reyes AA, Rothstein M: Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 1995;47:740–745.
- Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell’Era P, Nico B, Roncali L, Dammacco F: Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999;93:2627–2636.
- Pelletier L, Regnard J, Fellmann D, Chabord P: An in vitro model for the study of human bone marrow angiogenesis: Role of hematopoietic cytokine. Lab Invest 2000;80:501–511.
- Bertolini F, Mancuso P, Gobbi A, Pruneri G: The thin red line: Angiogenesis in normal and malignant hematopoiesis. Exp Hematol 2000;28:993–1000.
- Vacca A, Ribatti D, Presta M, Minischetti M, Iurlaro M, Ria R, Albini A, Bussolino F, Dammacco F: Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 1999;93:3064–3073.
- Perez-Atayade AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J: Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997;150:815–821.
- Padro T, Ruiz S, Bieker R, Burger H, Steins M, Kieast J, Buchner T, Berdel WE, Mesters RM: Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000;95:2637–2644.
- Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W, Wu Y, Chadburn A, Hyjek E, Gill M, Hicklin DJ, Moore MAS, Rafii S: Autocrine stimulation of VEGFR-2 activated human leukemic cell growth and migration. J Clin Invest 2000;106:511–521.
- Dankbar B, Padro T, Leo R, Feldmann B, Kropff M, Mesters RM, Serve H, Berdel WE, Kienast J: Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood 2000;95:2630–2636.
- Talks KL, Harris AL: Current status of antiangiogenic factors. Br J Haematol 2000;109:477–489.
Anderson KC: Thalidomide: Therapeutic potential in hematologic malignancies. Semin Hematol 2000;37(suppl 3):1–4.
- Vacca A, Iurlaro M, Ribatti D, Minischetti M, Nico B, Ria R, Pellegrino A, Dammacco F: Antiangiogenesis is produced by nontoxic doses of vinblastine. Blood 1999;94:4143–4155.
- Kerbel KS, Viloria-Petit A, Klement G, Rak J: ‘Accidental’ anti-angiogenic drugs: Anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples. Eur J Cancer 2000;36:1248–1257.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.